Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Letter to Congress Regarding the Advancing Access to Precision Medicine Act
-
ACMG Responds to FDA’s Approval for DTC Testing for Three BRCA Gene Mutations
-
ACMG Response to Expansion of Direct-to-Consumer Genetic Testing
-
ACMG Testimony in Support of the Accurate Education for Prenatal Screenings Act (HR 3441)
-
ACMG Letter to Congress Supporting the Accurate Education for Prenatal Screenings Act (HR 3441)
-
Joint Comments to CMS Concerning MolDx Program, Medicare Coverage, and Impact on MoPath Gapfill Determinations
-
ACMG Letter to Palmetto GBA Requesting Reconsideration of Cytogenetic Microarray Coverage
-
ACMG Applauds Supreme Court Decision on Gene Patents
-
ACMG Joins Amicus Brief in Mayo v. Prometheus to Counter Patents on Observations of Natural Phenomena
-
ACMG Comments to NIH about Development of the Genetic Test Registry